No filter, high-puff frequency, higher quantities of nicotine and tar in bidi The Tribune, now published from Chandigarh, ...

Lung cancer remains the most frequently diagnosed cancer globally, with 2.5 million new cases, representing 12.4% of all ...

The most common types of lung cancer are non-small cell lung cancer (NSCLC)—which accounts for 80% to 85% of diagnosed cases of the disease in the United States—and small cell lung cancer (SCLC). Each ...

Efti + KEYTRUDA combo shows strong efficacy for NSCLC patients in Immutep's phase 1 study. Read why IMMP stock may see upside ...

Most lung cancers are called non-small cell lung cancer (NSCLC). This group includes: adenocarcinoma squamous cell carcinoma large cell carcinoma ALK-positive lung cancer The second, smaller ...

Cadonilimab is included for the treatment of relapsed or metastatic cervical cancer (R/M CC) patients who progressed on or after platinum-based chemotherapy. Ivonescimab is included for the treatment ...

During a Case-Based Roundtable® event, Patrick M. Forde, MD, discussed safety and tolerability concerns with immunotherapy in ...

Oct. 9, 2024 — Researchers have demonstrated that patients with metastatic non-squamous non-small cell lung cancer (NSCLC) harboring specific mutations in the STK11 ... Scientists Discover That ...

EGFR-positive lung cancer is a type of lung cancer with an epidermal growth factor receptor (EGFR) mutation. In the United States, around 10% to 15% of lung cancers are EGFR-positive. Most of these ...

Bevacizumab biosimilars have the potential to expand access and reduce costs without compromising patient outcomes in ...

LUNGevity Foundation and Rising Tide Foundation for Clinical Cancer Research are proud to support Abhijit Patel, MD, PhD, Yale University School of Medicine, with the 2024 Rising Tide Foundation for ...